MERLYN MCDONALD: Open Payments
NPI 1033268677 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$962 in 27 payments from 21 companies in 2025. Trend: 2023 $1,519 · 2024 $0 · 2025 $962
Food & beverage: $729Education: $233
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $177 |
| Eisai Inc. | 1 | $121 |
| Genmab U.S., Inc. | 1 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $86 |
| SEAGEN INC. | 1 | $80 |
| SpringWorks Therapeutics, Inc. | 1 | $56 |
| PUMA BIOTECHNOLOGY, INC. | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Gilead Sciences, Inc. | 1 | $28 |
| SERVIER PHARMACEUTICALS LLC | 1 | $25 |
Products named: Leqembi, Epkinly, LYNPARZA, NERLYNX, OPDIVO, IMFINZI, Trodelvy, IDHIFA.
Industry payments across FL — which companies pay providers there.
